COLCOT

Efficacy and safety of low-dose colchicine after myocardial infarction - The New England Journal of Medicine – 2019

Brief Summary:

In patients with MI in the last 30 days, colchicine was associated with a 1.6% absolute reduction in the primary composite endpoint of death from cardiovascular causes, resuscitated cardiac arrest, recurrent MI, stroke, or urgent hospitalization for angina leading to coronary revascularization at median 22.6 months.

Reference:
http://www.ncbi.nlm.nih.gov/pubmed/31733140